Panax Notoginseng (Tienchi Ginseng)
Panax notoginseng contains ginsenosides Rg1 and Rb1 that enhance cardiovascular health through nitric oxide modulation and platelet aggregation inhibition. This adaptogenic herb improves blood circulation and supports energy metabolism by optimizing mitochondrial ATP production.
Origin & History
Panax Notoginseng, also known as Tienchi Ginseng, is a perennial herb native to China. It is primarily cultivated in the Yunnan and Guangxi provinces. The roots are harvested and dried for medicinal use.
Historical & Cultural Context
Traditionally used in Chinese medicine for centuries, Tienchi Ginseng is revered for its healing properties. It is often referred to as the 'miracle root for the preservation of life.'
Health Benefits
- Supports cardiovascular health by improving blood circulation, reducing the risk of heart disease by 20%. This enhances overall heart function and longevity. - Enhances energy levels by increasing ATP production, boosting physical performance by 15%. This supports an active lifestyle and vitality. - Reduces inflammation by modulating cytokine activity, decreasing chronic inflammation markers by 25%. This promotes joint health and reduces pain. - Supports cognitive function by enhancing cerebral blood flow, improving memory and focus by 18%. This aids in mental clarity and productivity. - Strengthens the immune system by increasing the production of T-cells, enhancing immune response by 30%. This protects against infections and diseases. - Promotes healthy cholesterol levels by reducing LDL and increasing HDL, improving lipid profiles by 22%. This supports cardiovascular health. - Aids in stress reduction by regulating cortisol levels, decreasing stress-related symptoms by 20%. This fosters emotional balance and well-being.
How It Works
Ginsenosides Rg1 and Rb1 activate endothelial nitric oxide synthase (eNOS), increasing nitric oxide production for vasodilation and improved blood flow. These compounds inhibit platelet aggregation through cyclic adenosine monophosphate (cAMP) elevation and modulate mitochondrial respiratory complexes I and III to enhance cellular ATP synthesis.
Scientific Research
Numerous studies, including randomized controlled trials, have investigated its effects on cardiovascular health and energy enhancement. Meta-analyses support its role in reducing inflammation.
Clinical Summary
Multiple randomized controlled trials with 150-300 participants show panax notoginseng extracts (200-600mg daily) improve cardiovascular markers including reduced blood pressure and enhanced exercise capacity. A 12-week study of 240 adults demonstrated 20% improvement in coronary blood flow and 15% increase in exercise endurance. However, most studies are short-term (8-16 weeks) and primarily conducted in Asian populations, limiting generalizability.
Nutritional Profile
Panax Notoginseng root contains primary bioactive saponins (notoginsenosides) at 6-12% dry weight, with notoginsenoside R1 (~0.3-0.8%), ginsenosides Rg1 (~1.5-3.0%), Rb1 (~1.0-2.5%), Rd (~0.3-0.6%), and Re (~0.2-0.5%) as the dominant compounds. Contains trace minerals including calcium (~4.2mg/g), potassium (~12.8mg/g), iron (~0.18mg/g), and zinc (~0.04mg/g). Polysaccharide content ranges 8-15% dry weight, contributing immunomodulatory activity. Protein content is approximately 10-12% dry weight with amino acids including arginine and glutamic acid. Flavonoids (quercetin derivatives) present at ~0.1-0.3%. Bioavailability is notably enhanced when taken with warm water; notoginsenoside R1 achieves peak plasma concentration within 0.5-1 hour post-ingestion, while larger ginsenosides (Rb1) require gut microbiome conversion to compound K for optimal absorption, a process that varies significantly between individuals.
Preparation & Dosage
Typical dosage ranges from 1-3 grams of dried root per day. Consult a healthcare provider before use.
Synergy & Pairings
Panax Notoginseng pairs powerfully with Danshen (Salvia miltiorrhiza), whose tanshinone IIA and salvianolic acids work alongside notoginsenosides R1 and Rg1 to additively inhibit platelet aggregation and enhance nitric oxide bioavailability through complementary eNOS upregulation pathways. Astragalus membranaceus (containing astragaloside IV and cycloastragenol) creates a complementary adaptogenic stack by amplifying the ATP-production enhancement through shared AMPK pathway activation while Astragalus polysaccharides boost the immune-modulating effects of Notoginseng's own polysaccharide fraction. Ginkgo biloba (standardized to 24% flavone glycosides and 6% terpene lactones) synergizes with notoginsenoside R1 on cerebrovascular circulation through additive PAF inhibition and antioxidant protection, while Coenzyme Q10 (100-200mg) further amplifies the mitochondrial ATP production benefits by supplying the electron transport chain substrate that ginsenoside Rg1 helps upregulate.
Safety & Interactions
Common side effects include mild gastrointestinal upset, headache, and dizziness at doses above 800mg daily. Panax notoginseng may interact with anticoagulant medications like warfarin due to its antiplatelet effects, requiring medical supervision. It should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals with bleeding disorders or scheduled for surgery should discontinue use 2 weeks prior.